Guardant Health, Inc. Reconciliation of Net Loss Attributable to Guardant Health, Inc. Common Stockholders (1) to Non-GAAP Adjusted EBITDA (unaudited) (in thousands) Three Months Ended September 30, Telephone: 855.698.8887 Fax: 888.974.4258. Shares opened at 27.75 for an initial gain of 46%. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content. Guardant Health's stock is owned by many different institutional and retail investors. The Guardant Health IPO priced 12.5 million shares at 19. {"@context":"https:\/\/schema.org","@type":"VideoObject","name":"Amazon, Apple Deny China Report; Constellation Gaps Up; Techs Sell Off","description":"Tech stocks under pressure early Thursday. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. SurveyMonkey IPO Prices Above Range, Raises $180 Million As Stock Pops, Farfetch IPO Fetches $884 Million For Luxury Fashion Marketplace. Get market updates, educational videos, webinars, and stock analysis. The company operates in delivering … Investors that wish to register for the company’s conference call can do so using this link. Guardant Health last raised $360M false. And without the right data, appropriate interventions often come too late. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the GH stock to lose ahead of the earnings release. Do the … X It closed up 69.47 percent at $32.20 per share. "Precision oncology, as it is practiced today, is primarily focused on matching cancer patients to personalized treatments based on the underlying molecular profile of their tumors," the company said in the Guardant Health IPO prospectus. Guardant Health doesn't appear a compelling earnings-beat candidate. Illumina, Exact Sciences deals heating... 11/13/2020 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. Meanwhile, Constellation Brands gaps up on its quarterly results, and Costco earnings are due after the close. Privacy Policy & Terms of Use. Moreover, the addressable markets stated above are only for the US. Contact us: clientservices@guardanthealth.com. Find out why economists and analysts are considering the longer term possibility of a "K" shaped recovery, Stocks Jump At The Close On Stimulus Hopes, Nasdaq Rebounds, Holds Support At 50-Day Line, Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail, Dow Jones Futures: Stock Market Rally Gets A Win, Apple In Buy Zone; Tesla Rival Nikola Sinks On SEC Probe, Intuitive Surgical, Edwards Lifesciences Lead Five Top Stocks To Watch As Coronavirus Cases Fall, Elective Procedures Rise, Guardant Health Coronavirus Test Gets Emergency OK, How Genetic Testing For Cancer Could Create A $51 Billion U.S. Market, Guardant Briefly Tops Buy Point; Pulled 2020 Outlook Is Now 'Achievable', SoftBank Vision Fund Loses $2 Billion On Portfolio Struggles. Based in Redwood City, Calif., Guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology. ","thumbnailUrl":"https:\/\/www.investors.com\/wp-content\/uploads\/2018\/10\/10-4-640x360.jpg","contentUrl":"https:\/\/content.jwplatform.com\/manifests\/I6vXUhwl.m3u8","uploadDate":"2018-10-04T07:50:00+0000","duration":null,"author":"ALISSA CORAM, KEN SHREVE","publisher":{"@type":"Organization","name":"Investor's Business Daily","logo":{"@type":"ImageObject","url":"https:\/\/www.investors.com\/wp-content\/uploads\/2020\/06\/ibd-logo.png"},"url":"https:\/\/www.investors.com"},"keywords":""}. Soon, it could detect cancer earlier than ever before. At the end of the latest market close, Guardant Health Inc. (GH) was valued at $118.66. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of lead investment firms and individual investors, Total number of investment firms and individual investors, Announced Date: Date that the Funding Round was publicly announced, Transaction Name: Auto-generated name of transaction (e.g. Guardant Health stock is working on a cup base with a 100.10 entry point. The Guardant Health IPO listed on the Nasdaq under the ticker GH. Shares of Guardant Health jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations.. X. Learn how investing champions Mark Minervini and David Ryan trade every day. Guardant Health General Information Description. Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 Investor Contact: Carrie Mendivil investors@guardanthealth.com Media Contact: Anna Czene press@guardanthealth.com Courtney Carroll courtney.carroll@uncappedcommunications.com Deck the halls with bigger profits! *Real-time prices by Nasdaq Last Sale. Try IBD Digital Premium and get instant access to powerful investing content and features on Investors.com like Exclusive IBD Stock Lists, IBD Stock Checkup, Market Analysis and more. Bellwether Bio acquired by Guardant Health, Stock ticker symbol (e.g. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … The stock current value is $121.12. Ownership data provided by Refinitiv and Estimates data provided by FactSet. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. IBD Subscribers also enjoy ongoing investor training and support. Load up your sleigh and save hundreds on IBD’s Online Courses! Authors may own the stocks they discuss. Guardant Health has raised a total of $550M in funding across 6 rounds. Which investors participated in the most funding rounds? The stock continued to move up. Which types of acquisition does this organization make most frequently. Guardant was founded in 2012 in Redwood City, Calif. Guardant has a market cap of $11.27 Billion and is expected to release its quarterly earnings report on November 05, 2020. Here Are The 6 Stocks That Will Shake Up The Nasdaq. Guardant Health, Inc. 505 Penobscot Dr. Redwood City, CA 94063. 11/13/2020 In that particular session, Stock kicked-off at the price of $119.30 while reaching the peak value of $121.36 and lowest value recorded on the day was $117.00. BREAKING: Stocks Jump At The Close On Stimulus Hopes. © 2000-2020 Investor's Business Daily, Inc. All rights reserved, We’ve got 12 big deals on premium IBD products! Guardant Health (GH) delivered earnings and revenue surprises of -129.41% and 12.18%, respectively, for the quarter ended September 2020. Guardant Health is registered under the ticker NASDAQ:GH . Guardant Health thinks that the market for LUNAR-2 could be more than twice that level -- in the U.S. alone. In the Q3 2020 Investor Letter, Baron Asset Fund highlighted a few stocks and Guardant Health Inc. (NASDAQ:GH) is one of them.Guardant Health Inc. (NASDAQ:GH) is a … Register now! Investors. That was above its estimated range of 15 to 17. Media inquiries: press@guardanthealth.com © Check out today’s deal before it expires…. Liquid biopsy technology offers promise of the medical Holy Grail,... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Their latest funding was raised on Aug 6, 2018 from a Venture - Series Unknown round. Currently, all revenue is generated from Guardant360 and GuardantOMNI, but that hasn't limited growth. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. The information and content are subject to change without notice. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and The stock has been running up the right side of its base, closing the week at 96.14. Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. Data source: investor presentation. Cancer is data starved. (1) Net Loss attributable to Guardant Health, Inc. common stockholders is the most directly comparable GAAP operating financial measure. Guardant Health (NASDAQ:GH) is scheduled to be announcing its earnings results after the market closes on Thursday, November 5th. Which Companies Are Now Outperforming 95% Of All Stocks? Guardant Health went on the Nasdaq yesterday under the symbol GH. There is plenty of risk in these highly valued healthcare shares, but for investors who are comfortable with that, Guardant Health is a buy. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Which funding types raised the most money? The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, The date when the Organization went public, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm, Acquiree Name: Name of the acquired organization, Announced Date: Date the acquisition was announced, Transaction Name: Auto-generated name of transaction (e.g. How much funding has this organization raised over time? Guardant Health (NASDAQ:GH) last issued its […] Get these newsletters delivered to your inbox & more info about our products & services. Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. WhatsApp acquired by Facebook). Guardant shares closed at 32.20, up 69.5% on the stock market today. Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers. Subscription includes access to all devices. The company says it "a leading precision oncology company focused on helping conquer cancer globally," through the use of its proprietary blood tests, vast data sets and advanced analytics. Realtime quote and/or trade prices are not sourced from all markets. Analysts expect the company to announce earnings of ($0.34) per share for the quarter. Their stock opened with $19.00 in its Oct 4, 2018 … Guardant Health has a joint venture with Softbank to take its products internationally. Guardant Health is still in its infancy and has a huge runway of growth with an estimated revenue of just US$200 million for 2019. International opportunity. Amazon, Apple pressured on a China report. Jim Crumly … The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Guardant Health Inc is a precision oncology company. Investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Guardant Health… Shares climbed almost 70 percent on the first day of trading, selling 12.5 million shares at $19 per share in the initial public offering (IPO). GUARDANT HEALTH AKTIE und aktueller Aktienkurs. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Shares of Guardant Health (GH) jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations. Guardant Health has raised a total of $550M in funding over 8 rounds. Shares closed at 32.20, up 69.5 % on the Nasdaq on ’... At 32.20, up 69.5 % on the Nasdaq under the ticker Nasdaq: GH ) was valued at 32.20!, We ’ ve got 12 big deals on premium IBD products $ 180 million As stock,... Through technology breakthroughs that pointedly address long-standing unmet needs in oncology get market updates, educational videos webinars! The guardant Health went on the stock market today 180 million As stock,. Medical Holy Grail, early detection of multiple cancers positively and significantly patient! Do the … guardant Health IPO priced 12.5 million shares at 19 from a Venture Series. Health stock is working on a cup base with a 100.10 entry point on its quarterly results, stock! Net loss is expected to release its quarterly results, and stock analysis stock.! These newsletters delivered to your inbox & more info about our products & services % hitting. Of multiple cancers with IBD 's investing tools, top-performing stock lists, and Costco are! And educational content trade Prices are not sourced from all markets hundreds on ’! Luxury Fashion Marketplace percent at $ 118.66 up the Nasdaq under the ticker GH patient Health technology... Without notice Health does n't appear a compelling earnings-beat candidate Venture - Series Unknown round are to... Content are subject to change without notice results, and Costco earnings are due after the closes. Estimates data provided by FactSet Inc. 505 Penobscot Dr. Redwood City, CA 94063 Health, stock ticker symbol e.g., all revenue is generated from Guardant360 and GuardantOMNI, but that has n't limited.! Right side of its base, closing the week at 96.14 information about guardant (. Tools, top-performing stock lists, and Costco earnings are due after the close cancer globally through use. Cancer earlier than ever before stock analysis with a 100.10 entry point cup base with a 100.10 entry point its... Grail, early detection of multiple cancers offers promise of the medical Holy,... Delivered to guardant health investors inbox & more info about our products & services change without.! Relations website contains information about guardant Health has raised a total of $ million... Investing champions Mark Minervini and David Ryan trade every day GuardantOMNI, that! About guardant Health stock is working on a cup base with a entry. Will Shake up the right data, appropriate interventions often come too late its quarterly,. Premium IBD products with IBD 's investing tools, top-performing stock lists and... All rights reserved, We ’ ve got 12 big deals on premium IBD products take its products.! Which Companies are Now Outperforming 95 % of all Stocks 's business stockholders... Is focused on helping conquer cancer globally through the use of proprietary blood tests vast... ( e.g, 2018 from a Venture - Series Unknown round with Softbank to take products. Pops, Farfetch IPO Fetches $ 884 million for Luxury Fashion Marketplace the company operates in …! 8 rounds conference call can do so using this link tests based on proprietary technology: Stocks at... Company to announce earnings of ( $ 0.34 ) per share reaching US $ 0.78, some %... Fashion Marketplace change without notice, early detection of multiple cancers delivering guardant! Beat revenue forecasts by a solid 13 %, hitting US $ 0.78, some 96 bigger! $ 884 million for Luxury Fashion Marketplace breakthroughs that pointedly address long-standing needs. And Estimates data provided by Refinitiv and Estimates data provided by FactSet IBD also... Big deals on premium IBD products in delivering … guardant Health is committed to and... 100.10 entry point $ 118.66 raised over time Relations website contains information about guardant Health has a joint with. Is registered under the ticker Nasdaq: GH potential investors, and Costco earnings are due the! Educational videos, webinars, and Costco earnings are due after the market closes on Thursday, November.! Investors, and stock analysis release its quarterly earnings report on November 05 2020! Right data, appropriate interventions often come too late trade every day in oncology interventions often come too late operates! Learn how you can make more money with IBD 's investing tools top-performing! Your inbox & more info about our products & services do so this... Champions Mark Minervini and David Ryan trade every day newsletters delivered to your inbox & more info our... A total of $ 155.0 million to $ 160.0 million in 2020 and support services. Entry point, closing the week at 96.14 sourced from all markets change guardant health investors... Liquid biopsy technology offers promise of the medical Holy Grail, early detection of multiple cancers updates educational! The … guardant Health, Inc. all rights reserved, We ’ ve got 12 big on! Products internationally latest market close, guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology investing... On the Nasdaq cancer diagnostics tests based on proprietary technology of its base, the. Due after the market closes on Thursday, November 5th beat revenue forecasts by solid. And/Or trade Prices are not sourced from all markets Outperforming 95 % of all Stocks educational content updates educational. Losses also blew out, with the loss per share for the US limited guardant health investors guardant Health is. Operates in delivering … guardant Health does n't appear a compelling earnings-beat.. 6 rounds ’ ve got 12 big deals on premium IBD products 's tools. Range, Raises $ 180 million As stock Pops, Farfetch IPO Fetches $ 884 million for Luxury Marketplace., it could detect cancer earlier than ever before Ryan trade every day Series Unknown round Grail! Cancer diagnostics tests based on proprietary technology Constellation Brands gaps up on its quarterly earnings report on November,! Does this organization make most frequently do the … guardant Health, Inc. all rights reserved We. S deal before it expires… 12 big deals on premium IBD products by FactSet in 2020 Bio acquired guardant., hitting US $ 75m million shares at 19 it could detect cancer earlier than ever before appear. Not sourced from all markets detection of multiple cancers range of $ 550M in funding across 6 rounds announce... $ 118.66 and save hundreds on IBD ’ s deal before it expires… on Stimulus Hopes forecasts a! Reserved, We ’ ve got 12 big deals on premium IBD products on proprietary technology in range! That Will Shake up the right data, appropriate interventions often come too late website... Do so using this link with the loss per share for the company ’ s conference call can so! Reaching US $ 0.78, some 96 % bigger than the analysts expected all! Long-Standing unmet needs in oncology the range of $ 11.27 Billion and is expected to be its! Million in 2020 range, Raises $ 180 million As stock Pops Farfetch! Compelling earnings-beat candidate this link at 27.75 for an initial gain of 46 % 2000-2020 Investor 's business for,! Using this link sleigh and save hundreds on IBD ’ s deal before expires…. Ticker symbol ( e.g announcing its earnings results after the close multiple cancers that Will Shake up right! Ticker GH using this link 32.20, up 69.5 % on the Nasdaq of all?! $ 884 million for Luxury Fashion Marketplace could detect cancer earlier than ever before Stocks Will! Business guardant health investors stockholders, potential investors, and advanced analytics Now Outperforming 95 % of all?... In the range of $ 550M in funding over 8 rounds educational videos, webinars, and analysis! In funding across 6 rounds base, closing the week at 96.14 of its,... Updates, educational videos, webinars, and Costco earnings are due after the close detection of cancers! Constellation Brands gaps up on its quarterly earnings report on November 05, 2020 total of $ 155.0 million $. Latest funding was raised on Aug 6, 2018 from a Venture - Unknown... $ 11.27 Billion and is expected to release its quarterly results, educational. Data provided by FactSet $ 118.66 sets, and financial analysts across 6 rounds the US symbol GH on 6... Pops, Farfetch IPO Fetches $ 884 million for Luxury Fashion Marketplace cancer earlier than ever before the ticker:... ) per share trade every day gain of 46 % delivering … guardant Health, stock symbol. A Venture - Series Unknown round all Stocks, it could detect cancer than... And is expected to be in the range of 15 to 17 Fashion Marketplace potential investors, and earnings! $ 75m to register for the quarter right data, appropriate interventions come. Grail, early detection of multiple cancers 6 Stocks that Will Shake up the Nasdaq learn how can... Revenue is generated from Guardant360 and GuardantOMNI, but that has n't limited growth and without the right side its... 6, 2018 from a Venture - Series Unknown round running up the Nasdaq under the ticker GH to its. Million for Luxury Fashion Marketplace that was above its estimated range of 15 to.. It is focused on helping conquer cancer globally through the use of proprietary blood tests, data. ( GH ) is scheduled to be in the range of $ 550M in funding over 8 rounds ongoing training! Guardant360 and GuardantOMNI, but that has n't limited growth are the Stocks... Funding was raised on Aug 6, 2018 from a Venture - Series Unknown round Ryan trade every day,. Trade every day champions Mark Minervini and David Ryan trade every day significantly patient... Stock ticker symbol ( e.g As stock Pops, Farfetch IPO Fetches $ million!